April Chen
AstraZeneca (South Korea)(KR)AstraZeneca (Brazil)(BR)AstraZeneca (United States)(US)
Publications by Year
Research Areas
Antibiotics Pharmacokinetics and Efficacy, Cancer Mechanisms and Therapy, Antibiotic Resistance in Bacteria, Liver physiology and pathology, Quinazolinone synthesis and applications
Most-Cited Works
- → Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase(2008)139 cited
- → Rational design of a new antibiotic class for drug-resistant infections(2021)137 cited
- → Discovery of a Potent, Selective, and Orally Bioavailable c-Met Inhibitor: 1-(2-Hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide (AMG 458)(2008)94 cited
- → Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated Efficacy(2015)76 cited
- → Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514(2017)59 cited
- → Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases(2020)59 cited